Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Tumor Immunotherapy01:27

Tumor Immunotherapy

484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Copper(II)-Mediated Mitochondria-Targeting in Cancer Cells.

Journal of medicinal chemistry·2026
Same author

Hybrid Aminoferrocenes With Nitrate Esters for In Situ Peroxynitrite Generation: Complex Interplay Between Redox Chemistry, NO-Donor Reactivity, and Aminoferrocene Activation Influences In Vitro Anticancer Activity.

Chembiochem : a European journal of chemical biology·2026
Same author

Dextran-driven hyperbranched black gold nanoparticles templated by guanosine quartets as broadband absorbers for photothermal therapy.

International journal of biological macromolecules·2026
Same author

The nitrogen starvation-induced inhibitor Rts3 restrains Sit4/PP6 to gate quiescence downstream of TORC1.

Nature communications·2026
Same author

Associations Between Systemic Inflammatory Markers, Metabolic Dysfunction, and Liver Fibrosis Scores in Patients with MASLD.

Metabolites·2026
Same author

Oral health status and access to oral healthcare among adult refugees in Egypt: a cross-sectional study.

BMC oral health·2026

相关实验视频

Updated: Jun 8, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

针对免疫性癌症细胞死亡的溶酶体醇.

Anton Arkhypov1, Insa Klemt1, Galyna Bila2,3

  • 1Friedrich-Alexander-University of Erlangen-Nürnberg (FAU), Department of Chemistry and Pharmacy, Organic Chemistry II, 91058, Erlangen, Germany.

Angewandte Chemie (International ed. in English)
|November 4, 2024
PubMed
概括

一种新的治疗剂,可逆醇结合剂11,向癌细胞溶解体,诱导细胞死亡和强大的抗瘤免疫力. 这种方法在临床前模型中显示出显著的疗效,为癌症治疗提供了一个有希望的新途径.

关键词:
癌症 癌症 癌症 癌症电友性药物 电友性药物免疫原性细胞死亡细胞内硫醇 (Thiol) 是一种细胞内硫醇.lysosome 是一个溶解体.

更多相关视频

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.6K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K

相关实验视频

Last Updated: Jun 8, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K
Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.6K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学

背景情况:

  • 溶解体 (LYs) 在癌细胞中表现出改变的数量和稳定性,呈现出治疗点.
  • 目前的治疗方法缺乏专门针对癌症治疗的溶酶体的批准药物.

研究的目的:

  • 研究一种新的治疗策略,使用可逆的醇结合剂 (化合物11) 向癌细胞溶解体.
  • 在临床前癌症模型中评估由化合物11诱导的疗效和免疫反应.

主要方法:

  • 用化合物11对癌细胞进行治疗,以诱导 lysosomal thiol 化.
  • 评估溶酶体活性氧物种 (ROS) 水平,溶酶体稳定性和癌细胞死亡.
  • 在小鼠肉瘤Nemeth-Kellner (NK) /Ly-RB模型中评估治疗效果.
  • 在治愈后的小鼠中分析幽默免疫反应和中性粒细胞活性.

主要成果:

  • 化合物11治疗增加了 lysosomal ROS,导致不稳定,干扰和免疫性癌细胞死亡.
  • 在NK/Ly-RB模型中,化合物11将中位生存时间从21天延长到85天,并治愈了40%的小鼠.
  • 治愈后的小鼠产生了针对瘤细胞的抗体,并在再次挑战时显示出100%的存活率,这表明获得了免疫力.
  • 治愈后小鼠中的中性粒细胞通过中性粒细胞外陷 (NETs) 显示出抗瘤活性.

结论:

  • 化合物11通过诱导溶酶体损伤和免疫细胞死亡来表现出直接的抗瘤作用.
  • 该疗法启动了针对癌细胞的幽默和中性粒细胞介导的免疫反应.
  • 这种针对溶酶体的方法代表了癌症特异性治疗的有希望的策略.